Evidence map›Paper›PMID 37265402›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2023

SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor.

Nicole O Ponde, Karsen E Shoger, Mst Shamima Khatun, Mrinal K Sarkar, Ipsita Dey, Tiffany C Taylor, Rylee N Cisney, Samyuktha P Arunkumar, Johann E Gudjonsson, Jay K Kolls and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Host factors of SARS-CoV-2 in infection, pathogenesis, and long-term effects.Frontiers in cellular and infection microbiology · 2024
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Nicole O PondeDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0003-2704-0451
Karsen E ShogerDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.
Mst Shamima KhatunTulane University, New Orleans, LA.
Mrinal K SarkarDepartment of Dermatology, University of Michigan, Ann Arbor, MI.ORCID 0000-0001-8505-4259
Ipsita DeyDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.
Tiffany C TaylorDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-4971-3728
Rylee N CisneyDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-8206-2955
Samyuktha P ArunkumarDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-1397-9399
Johann E GudjonssonDepartment of Dermatology, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-0080-0812
Jay K KollsTulane University, New Orleans, LA.ORCID 0000-0001-5151-6304
Rachel A GottschalkDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-5248-8816
Sarah L GaffenDivision of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0001-8511-2041
University of Pittsburgh · USTulane University · USUniversity of Michigan · US

Funding

Autoimmunity and Immunopathology Training ProgramT32AI089443 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHLOMCHIK, MARK J · 2010 to 2024
$6.6M
University of Michigan Skin Biology and Diseases Resource-based CenterP30AR075043 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Johann Eli Gudjonsson · 2019 to 2026
$6.6M
Training in CD4 T-cell Lung ImmunityR35HL139930 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI KOLLS, JAY K · 2018 to 2024
$6.3M
RNA binding proteins in end-organ autoimmune pathologyR01AI162616 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sarah L Gaffen · 2022 to 2026
$3.2M
Molecular Mechanisms of IL-17-dependent autoimmune signalingR01AI147383 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2020 to 2024
$2.6M
Quantitative control of phosphorylation and mechanistic links to immune cell decisionsR35GM146896 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Rachel A Gottschalk · 2022 to 2026
$2.0M
NHLBI NIH HHS R35 HL139930NIAID NIH HHS R01 AI147383NIAID NIH HHS R01 AI162616NIAID NIH HHS T32 AI089443NIAMS NIH HHS P30 AR075043NIGMS NIH HHS R35 GM146896
6 · The paper itself

Abstract

SARS-CoV-2 has caused an estimated 7 million deaths worldwide to date. A secreted SARS-CoV-2 accessory protein, known as open reading frame 8 (ORF8), elicits inflammatory pulmonary cytokine responses and is associated with disease severity in COVID-19 patients. Recent reports proposed that ORF8 mediates downstream signals in macrophages and monocytes through the IL-17 receptor complex (IL-17RA, IL-17RC). However, generally IL-17 signals are found to be restricted to the nonhematopoietic compartment, thought to be due to rate-limiting expression of IL-17RC. Accordingly, we revisited the capacity of IL-17 and ORF8 to induce cytokine gene expression in mouse and human macrophages and monocytes. In SARS-CoV-2-infected human and mouse lungs, IL17RC mRNA was undetectable in monocyte/macrophage populations. In cultured mouse and human monocytes and macrophages, ORF8 but not IL-17 led to elevated expression of target cytokines. ORF8-induced signaling was fully preserved in the presence of anti-IL-17RA/RC neutralizing Abs and in Il17ra-/- cells. ORF8 signaling was also operative in Il1r1-/- bone marrow-derived macrophages. However, the TLR/IL-1R family adaptor MyD88, which is dispensable for IL-17R signaling, was required for ORF8 activity yet MyD88 is not required for IL-17 signaling. Thus, we conclude that ORF8 transduces inflammatory signaling in monocytes and macrophages via MyD88 independently of the IL-17R.

Indexed as

COVID-19Open Reading FramesSARS-CoV-2AnimalsCytokinesHumansMacrophagesMiceMonocytesMyeloid Differentiation Factor 88Receptors, Interleukin-17CytokinesMYD88 protein, humanMyeloid Differentiation Factor 88Receptors, Interleukin-17

Identifiers

PMID37265402
PMCPMC10330444
OpenAlexW4379094017

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.